PD1 and PDL1 upregulation and survival after decitabine treatment in lower risk MDS

Leuk Lymphoma. 2017 Apr;58(4):764-765. doi: 10.1080/10428194.2016.1251594. Epub 2016 Nov 3.

Authors

Sameem Abedin¹, Leonidas C Platanias^{1

2}

Affiliations

¹ a Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Feinberg School of Medicine , Northwestern University , Chicago , IL , USA.
² b Department of Medicine , Jesse Brown Veterans Affairs Medical Center , Chicago , IL , USA.

PMID: 27808592
DOI: 10.1080/10428194.2016.1251594

No abstract available

Publication types

Comment

MeSH terms

Azacitidine* / analogs & derivatives
B7-H1 Antigen / genetics
Decitabine
Humans
Myelodysplastic Syndromes
Up-Regulation*

Substances

B7-H1 Antigen
Decitabine
Azacitidine